PROEHL GERALD T
Insider CIK 1279191 · SNTS President & CEO, Director · ASPX Director · RTTR Director · SPHS Director · DRMA President, CEO and Chairman, Director, 10% owner · TENX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 170,068 | — | $0 | 170,068 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 1,360,544 | — | $0 | 1,360,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 1,360,544 | — | $0 | 1,360,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 1,360,544 | — | $0 | 1,360,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 170,068 | — | $0 | 170,068 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2026-08-16 | 2026-08-18 | 170,068 | — | $0 | 292,631 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 1,360,544 | — | — | 1,360,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 170,068 | — | — | 170,068 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 170,068 | — | — | 170,068 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 1,360,544 | — | — | 1,360,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-08-16 | 2026-08-18 | 1,360,544 | — | — | 1,360,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2026-08-16 | 2026-08-18 | 170,068 | — | — | 292,631 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2026-01-09 | 2026-01-13 | 3,000 | — | $0 | 30,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 37,500 | — | $0 | 37,500 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | D To issuer deriv | 2025-12-23 | 2025-12-29 | 78,740 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-12-23 | 2025-12-29 | 78,740 | — | $0 | 78,740 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-12-23 | 2025-12-29 | 122,549 | — | $0 | 122,549 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-12-23 | 2025-12-29 | 122,549 | — | $0 | 122,549 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-12-23 | 2025-12-29 | 490,196 | — | $0 | 490,496 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-12-23 | 2025-12-29 | 490,196 | — | $0 | 490,496 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2025-12-23 | 2025-12-29 | 490,196 | — | $0 | 490,255 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2025-12-23 | 2025-12-29 | 122,549 | — | $0 | 122,563 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-21 | 2025-01-23 | 787,402 | — | $0 | 787,402 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2025-01-21 | 2025-01-23 | 787,402 | — | $0 | 799,508 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-13 | 2025-01-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy deriv | 2024-08-08 | 2024-08-08 | 16,660 | — | $0 | 16,660 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy deriv | 2024-08-08 | 2024-08-08 | 31,654 | — | $0 | 31,654 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2024-08-08 | 2024-08-08 | 1,666 | — | $0 | 1,667 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 4,517 | — | $0 | 4,517 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 42,141 | — | $0 | 42,141 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 57,859 | — | $0 | 57,859 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 197,610 | — | $0 | 197,610 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | P Buy | 2021-11-23 | 2021-11-26 | 20,000 | $2.40 | $48.0K | 59,512 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 60,240 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 3,722,500 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 2,295,000 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 2,436,657 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 241,325 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 25,582,050 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 120,481 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | P Buy deriv | 2021-08-17 | 2021-08-17 | 142,857 | — | $0 | 142,857 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 27,987 | — | $0 | 27,987 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 573,750 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 1,755,622 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 361,147 | — | $0 | 1,278,464 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 85,640 | — | $0 | 2,905,544 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 1,247,904 | — | $0 | 2,819,904 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 181,585 | — | $0 | 1,572,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 111,951 | — | $0 | 1,390,415 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | P Buy | 2021-08-17 | 2021-08-17 | 142,857 | — | $0 | 152,857 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 35,767 | — | $0 | 35,767 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 8,928 | — | $0 | 8,928 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 17,857 | — | $0 | 17,857 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | P Buy | 2021-08-16 | 2021-08-17 | 10,000 | $4.96 | $49.6K | 10,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2021-06-10 | 2021-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2020-05-01 | 2020-05-15 | 500 | — | $0 | 500 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2019-06-27 | 2019-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2018-06-27 | 2018-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2018-05-01 | 2019-04-18 | 500 | — | $0 | 500 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2018-01-23 | 2018-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2017-05-30 | 2017-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2016-11-29 | 2016-11-30 | 7,000 | — | $0 | 7,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2016-11-23 | 2016-11-29 | 14,449 | $1.76 | $25.4K | 29,882 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2016-11-22 | 2016-11-29 | 15,433 | $1.59 | $24.5K | 15,433 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2016-05-27 | 2016-05-31 | 8,250 | — | $0 | 8,250 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | A Award deriv | 2015-10-13 | 2015-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTTR RITTER PHARMACEUTICALS INC | P Buy | 2015-06-24 | 2015-06-25 | 50,000 | $5.00 | $250.0K | 50,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2015-05-27 | 2015-05-28 | 8,250 | — | $0 | 8,250 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 13,333 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 6,667 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-06 | 1,466 | — | $0 | 0 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | P Buy | 2014-09-19 | 2014-09-19 | 10,000 | $3.16 | $31.6K | 10,000 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-09-19 | 2014-09-22 | 1,466 | $21.75 | $31.9K | 1,466 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2014-06-17 | 2014-06-18 | 1,627 | — | $0 | 1,627 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | A Award deriv | 2014-05-06 | 2014-05-07 | 6,667 | — | $0 | 6,667 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2014-03-24 | 2014-03-24 | 16,500 | — | $0 | 16,500 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 281,335 | $27.37 | $7.70M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 16,408 | — | $0 | 246,092 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 258,058 | $28.67 | $7.40M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 11,942 | — | $0 | 258,058 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 337,500 | $27.07 | $9.14M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 450,000 | $16.58 | $7.46M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 39,889 | $24.85 | $991.2K | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 60,111 | — | $0 | 39,889 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 40,000 | $25.62 | $1.02M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 85,494 | $25.21 | $2.16M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 14,506 | — | $0 | 85,494 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 200,545 | $25.10 | $5.03M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 24,455 | — | $0 | 200,545 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 40,000 | $29.64 | $1.19M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 223,743 | $29.64 | $6.63M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 16,257 | — | $0 | 223,743 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 189,003 | $29.70 | $5.61M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 70,997 | — | $0 | 189,003 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 246,092 | $28.67 | $7.06M | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2014-01-02 | 2014-01-06 | 18,665 | — | $0 | 281,335 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 11,942 | $3.33 | $39.8K | 263,879 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 16,257 | $2.36 | $38.4K | 145,867 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 70,997 | $1.18 | $83.8K | 216,864 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 18,665 | $4.63 | $86.4K | 235,529 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 14,506 | $6.79 | $98.5K | 105,155 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 60,111 | $7.15 | $429.8K | 90,649 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 298,033 | $32.00 | $9.54M | 0 | SEC↗ |
| SNTS SANTARUS INC | F Tax w/h | 2014-01-02 | 2014-01-06 | 31,249 | $32.00 | $1000.0K | 298,033 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 30,538 | $32.00 | $977.2K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer | 2014-01-02 | 2014-01-06 | 233,341 | $32.00 | $7.47M | 30,538 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 24,455 | $6.90 | $168.7K | 129,610 | SEC↗ |
| SNTS SANTARUS INC | A Award | 2014-01-02 | 2014-01-06 | 16,408 | $3.33 | $54.6K | 251,937 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-12-16 | 2013-12-17 | 56,643 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-12-16 | 2013-12-17 | 56,643 | $3.50 | $198.3K | 87,181 | SEC↗ |
| SNTS SANTARUS INC | G Gift | 2013-12-16 | 2013-12-17 | 56,643 | — | $0 | 30,538 | SEC↗ |
| SNTS SANTARUS INC | G Gift | 2013-12-16 | 2013-12-17 | 56,643 | — | $0 | 385,925 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-12-16 | 2013-12-17 | 56,643 | $31.95 | $1.81M | 329,282 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-11-15 | 2013-11-19 | 56,644 | — | $0 | 56,643 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-11-15 | 2013-11-19 | 56,644 | $32.02 | $1.81M | 329,282 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-11-15 | 2013-11-19 | 56,644 | $3.50 | $198.3K | 86,834 | SEC↗ |
| SNTS SANTARUS INC | G Gift | 2013-11-15 | 2013-11-19 | 56,644 | — | $0 | 30,190 | SEC↗ |
| SNTS SANTARUS INC | G Gift | 2013-11-15 | 2013-11-19 | 56,644 | — | $0 | 385,926 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-10-15 | 2013-10-16 | 50,000 | $22.32 | $1.12M | 329,282 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-09-16 | 2013-09-17 | 50,000 | $22.19 | $1.11M | 379,282 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-05-06 | 2013-05-07 | 86,603 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-05-06 | 2013-05-07 | 86,603 | $0.88 | $76.2K | 160,740 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-05-06 | 2013-05-07 | 86,603 | $18.73 | $1.62M | 74,137 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-04-04 | 2013-04-05 | 86,601 | — | $0 | 86,603 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-04-04 | 2013-04-05 | 86,601 | $16.75 | $1.45M | 457,707 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-04-04 | 2013-04-05 | 86,601 | $0.88 | $76.2K | 544,308 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2013-03-11 | 2013-03-12 | 450,000 | — | $0 | 450,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-03-04 | 2013-03-05 | 86,601 | — | $0 | 173,204 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-03-04 | 2013-03-05 | 86,601 | $13.57 | $1.18M | 457,707 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-03-04 | 2013-03-05 | 86,601 | $0.88 | $76.2K | 544,308 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-02-04 | 2013-02-05 | 86,601 | — | $0 | 259,805 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-02-04 | 2013-02-05 | 86,601 | $0.88 | $76.2K | 544,308 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-02-04 | 2013-02-05 | 86,601 | $12.98 | $1.12M | 457,707 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2012-03-12 | 2012-03-13 | 337,500 | — | $0 | 337,500 | SEC↗ |